Fumihito Tajima

1.0k total citations
29 papers, 741 citations indexed

About

Fumihito Tajima is a scholar working on Hematology, Immunology and Hepatology. According to data from OpenAlex, Fumihito Tajima has authored 29 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Immunology and 8 papers in Hepatology. Recurrent topics in Fumihito Tajima's work include Hematopoietic Stem Cell Transplantation (9 papers), Immunotherapy and Immune Responses (5 papers) and Liver physiology and pathology (4 papers). Fumihito Tajima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Immunotherapy and Immune Responses (5 papers) and Liver physiology and pathology (4 papers). Fumihito Tajima collaborates with scholars based in Japan, United States and Mexico. Fumihito Tajima's co-authors include Makio Ogawa, Tatsuya Ito, Joseph Laver, Akira Endo, Takashi Sato, Hajime Kawasaki, Takao Deguchi, Goshi Shiota, Eiji Nanba and Hironaka Kawasaki and has published in prestigious journals such as Blood, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Fumihito Tajima

28 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumihito Tajima Japan 14 287 234 209 191 145 29 741
Takehide Akiyama Japan 10 446 1.6× 263 1.1× 167 0.8× 164 0.9× 51 0.4× 28 825
Haruko Shima Japan 13 593 2.1× 505 2.2× 207 1.0× 266 1.4× 22 0.2× 34 1.2k
T M Dexter United Kingdom 15 399 1.4× 225 1.0× 241 1.2× 227 1.2× 17 0.1× 24 822
Nobuyasu Takahashi Japan 10 152 0.5× 263 1.1× 60 0.3× 38 0.2× 64 0.4× 30 591
LG Bennett United States 10 227 0.8× 250 1.1× 350 1.7× 115 0.6× 15 0.1× 12 753
Feier Feng China 11 167 0.6× 122 0.5× 66 0.3× 147 0.8× 22 0.2× 26 446
Megan Kaba United States 4 277 1.0× 281 1.2× 112 0.5× 180 0.9× 13 0.1× 4 675
Wei Xie United States 17 203 0.7× 370 1.6× 259 1.2× 165 0.9× 10 0.1× 55 986
Marc Shuman United States 11 126 0.4× 396 1.7× 62 0.3× 259 1.4× 20 0.1× 20 1.1k
Angelika M. Dräger Netherlands 13 323 1.1× 205 0.9× 261 1.2× 125 0.7× 10 0.1× 22 784

Countries citing papers authored by Fumihito Tajima

Since Specialization
Citations

This map shows the geographic impact of Fumihito Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihito Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihito Tajima more than expected).

Fields of papers citing papers by Fumihito Tajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihito Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihito Tajima. The network helps show where Fumihito Tajima may publish in the future.

Co-authorship network of co-authors of Fumihito Tajima

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihito Tajima. A scholar is included among the top collaborators of Fumihito Tajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihito Tajima. Fumihito Tajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adachi, Koji, Fumihito Tajima, Kentaro Hara, et al.. (2025). Acute hemolytic crises and clinical course in a Japanese family with Hb Santander: a detailed case report. International Journal of Hematology. 122(6). 901–907.
2.
Tajima, Fumihito, et al.. (2017). Effect of Azacitidine on CD4+CD25+Foxp3+ Regulatory T Cell on Immunity in Myelodysplastic Syndrome Survivors. Blood. 130. 1703–1703. 1 indexed citations
3.
Tajima, Fumihito, et al.. (2017). BLOOD TRANSFUSION THERAPY IN TOTTORI: AN ANALYSIS OF QUESTIONNAIRE FINDINGS. Japanese Journal of Transfusion and Cell Therapy. 63(1). 40–45. 2 indexed citations
5.
Tajima, Fumihito, Hiroyuki Tsuchiya, K Nishikawa, et al.. (2010). Hepatocyte growth factor mobilizes and recruits hematopoietic progenitor cells into liver through a stem cell factor‐mediated mechanism. Hepatology Research. 40(7). 711–719. 13 indexed citations
6.
Sunami, Kazutaka, Katsuji Shinagawa, Morio Sawamura, et al.. (2009). Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma. International Journal of Hematology. 90(5). 635–642. 7 indexed citations
7.
Ishii, Kyoko, Yoko Yoshida, Yuji Akechi, et al.. (2008). Hepatic differentiation of human bone marrow–derived mesenchymal stem cells by tetracycline‐regulated hepatocyte nuclear factor 3β†. Hepatology. 48(2). 597–606. 81 indexed citations
8.
Sugihara, Shinobu, Yasutaka Yamamoto, Koichi Matsubara, et al.. (2006). Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans. Heart and Vessels. 21(4). 258–262. 13 indexed citations
9.
Shimomura, Takashi, Yoko Yoshida, Takamasa Kanbe, et al.. (2005). Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts. Biochemical and Biophysical Research Communications. 335(3). 723–729. 6 indexed citations
10.
Nakamura, Yuki, Fumihito Tajima, Hidetoshi Yamazaki, et al.. (2004). Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Experimental Hematology. 32(4). 390–396. 51 indexed citations
11.
Miake, Junichiro, Norihito Sasaki, Shuichi Yano, et al.. (2004). Developmental Changes of Ni2+ Sensitivity and Automaticity in Nkx2.5-Positive Cardiac Precursor Cells From Murine Embryonic Stem Cell. Circulation Journal. 68(7). 724–726. 8 indexed citations
12.
Tajima, Fumihito, et al.. (2002). Serum Soluble IL-6 Receptor Levels During the Mobilization of Stem Cells to Peripheral Blood. Leukemia & lymphoma. 43(3). 623–630. 2 indexed citations
13.
Suou, Takeaki, et al.. (2001). Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. European Journal Of Haematology. 67(1). 45–50. 78 indexed citations
14.
Suou, Takeaki, et al.. (2001). Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia. International Journal of Hematology. 73(1). 115–118. 16 indexed citations
15.
Ogawa, Makio, Fumihito Tajima, Tatsuya Ito, et al.. (2001). CD34 Expression by Murine Hematopoietic Stem Cells. Annals of the New York Academy of Sciences. 938(1). 139–145. 45 indexed citations
16.
Ito, Tatsuya, Fumihito Tajima, & Makio Ogawa. (2000). Developmental changes of CD34 expression by murine hematopoietic stem cells. Experimental Hematology. 28(11). 1269–1273. 90 indexed citations
17.
Tajima, Fumihito, et al.. (1998). Serum soluble c‐kit receptor and expression of c‐kit protein and mRNA in acute myeloid leukemia. European Journal Of Haematology. 60(5). 289–296. 29 indexed citations
18.
Tajima, Fumihito, et al.. (1996). Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.. PubMed. 10(3). 478–82. 80 indexed citations
19.
Suou, Takeaki, et al.. (1995). Effect of screening of donors for antibodies to hepatitis C virus by second-generation assay on incidence of HCV infection in acute leukemia. International Hepatology Communications. 4(3). 139–141. 1 indexed citations
20.
Horie, Yutaka, et al.. (1995). Clinical usefulness of cimetidine treatment for acute relapse in intermittent porphyria. Clinica Chimica Acta. 234(1-2). 171–175. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026